{
  "retracted": false,
  "timestamp": 1483228800000,
  "updates": [
    {
      "timestamp": 1585337588330,
      "identifier": {
        "doi": "10.1016/j.ejca.2016.11.001"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.ejca.2016.03.068"
  },
  "publisher": "Elsevier BV",
  "title": "Corrigendum to ‘Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models’ [Eur J Cancer 61 (2016) 20–28]"
}
